MRNS   $0.55  0.09% Market Open

Marinus Pharmaceuticals, Inc.

EMA (20): 2024-12-26 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (50): 2024-12-30 the price crossed up the moving average line and demonstrates an upside trend.

EMA (100): 2024-02-28 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in overbought territory and it grows. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

Trend Type down and flat
Power strong
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 70.38%
EMA (20) date of signal Dec. 26, 2024, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 3.75%
EMA (50) date of signal Dec. 30, 2024, 3 a.m.
EMA (100) Signals None
EMA (100) Yield 0.0
EMA (100) date of signal
RSI Signals bullish recovery
RSI (14) Yield 0.09%
RSI (14) date of signal Feb. 7, 2025, 3 a.m.
MACD Signals bearish reversal
MACD Yield 0.97%
MACD date of signal Jan. 22, 2025, 3 a.m.
Stochastic Signals bullish
Stochastic Yield 0.04%
Stochastic date of signal Feb. 5, 2025, 3 a.m.
Updated Feb. 12, 2025, 11:11 p.m.